Geriatric Assessments Should Guide Treatment Decisions in Older Patients
Breast cancer clinicians today are faced with an ever-expanding number of older patients, yet determining the most appropriate treatment for these individuals can be challenging.
Anticipatory and Delayed Nausea Remain Concerns for Patients on Chemotherapy
Despite progress in treating chemotherapy-induced nausea and vomiting, especially in the acute phase up to 24 hours after treatment, the condition is still one of the side effects patients fear most.
Cancer Treatment-It's Personal Now
The majority of the new oncology drugs approved inÂ 2012 are oral agents, and by reviewing the indications for these agents, it's easy to see how genetics impacts the agent's efficacy.
Counseling BRCA, Lynch Carriers on Prophylactic Oophorectomy
Due to the high lifetime risk of ovarian cancer and the poor ovarian cancer surveillance options available, women who carry BRCA1 or BRCA2 mutations are advised to remove their ovaries and fallopian tubes by age 40 or when childbearing is complete.
Journal Club Bridges Research and Practice, Improving Patient Care
Three oncology nurses at the Smilow Cancer Hospital at Yale-New Haven write about the Smilow Society, an interactive and innovative journal club enabling nurses to stay abreast of important research developments, which can then be translated directly into clinical practice.
Nurses Leading the Way: Promoting Adherence to Oral Cancer Medications
Spoelstra, PhD, RN, of the Michigan State University
College of Nursing, outlines the essential and
growing role of oncology nurses in helping patients
with cancer to manage their oral regimens
Managing Menopausal Symptoms in Breast Cancer Patients
J. Michael Dixon, MD, describes a number of effective options for clinicians to help patients better manage menopausal symptoms in patients with breast cancer and improve their quality of life.
Framing the Mastectomy Debate-The Trends
A review of several studies examining the long-term benefits of breast-conservation therapy compared with mastectomy for women with stage breast cancer.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512